As of July 2026, 77 paid clinical trials are recruiting in Fairway, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fairway offers studies at sites including University of Kansas Clinical Research Center for conditions such as Acute Myeloid Leukemia, Myelodysplastic Syndrome, Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Fairway, KS at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Clinical Research Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm | 31 |
| University of Kansas Medical Center | ASCVD, Alzheimer Disease, Amyotrophic Lateral Sclerosis | 7 |
| The University of Kansas Cancer Center | Advanced Breast Cancer, Advanced Solid Tumors With KRAS G12C Mutations, Aggressive B-Cell Non-Hodgkin Lymphoma | 5 |
| University of Kansas Cancer Center | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) | 5 |
| The University of Kansas Clinical Research Center | Acute Myeloid Leukemia, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer | 4 |
| University of Kansas | Acute Myeloid Leukemia (AML), Advanced Breast Cancer, Advanced Solid Tumors | 4 |
| The University of Kansas Cancer Center (KUCC) | NSCLC Stage IV, Breast Cancer, Lung Cancer | 3 |
| The University of Kansas - Clinical Research Center | Amyloid, Cognitive Dysfunction, Lewy Body Disease | 2 |
| University of Kansas Hospital | Alzheimer's Disease, Huntington Disease | 2 |
| A20 | Myasthaenia Gravis | 1 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| KU Clinical Research Center - Clinical and Translational Science Unit (CTSU) | Myositis | 1 |
| Kansas University Cancer Center | Advanced EGFR Positive Solid Tumor | 1 |
| Kansas University Medical Center | Acute Graft-versus-host Disease, Adverse Effects, Allogeneic Bone Marrow Transplantation | 1 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis | 1 |
| The University of Kansas Cancer Center ,Investigational Drug Services | Acute Myeloid Leukemia, Myelodysplastic Syndrome | 1 |
| The University of Kansas Cancer Center Kucc University of Kansas Clinical Research Center | Myeloproliferative Neoplasms | 1 |
| The University of Kansas Cancer Center, Investigational Drug Services | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 1 |
| The University of Kansas Hospital | Relapsed or Resistant Acute Leukaemias | 1 |
| The University of Kansas Medical Center Research Institute | AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent | 1 |
| University of Kansas Medical Center (KUMC) | Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer | 1 |
| University of Kansas Medical Center, Department of Neurology | Myotonic Dystrophy 1 | 1 |
Recruiting trials in Fairway grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 77 recruiting clinical trials in Fairway, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Fairway compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Fairway include Acute Myeloid Leukemia (9), Myelodysplastic Syndrome (4), Stage IV Lung Cancer AJCC v8 (4), Metastatic Malignant Solid Neoplasm (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairway on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Fairway include University of Kansas Clinical Research Center, University of Kansas Medical Center, The University of Kansas Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Fairway are Cancer & tumors (42), Neurology & pain (3), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.